Articles tagged with Analgesics
A study published in Nature Chemical Biology found that a molecular switch in the nerves responsible for detecting pain can 'short-circuit', intensifying pain. This alternative pathway activates the pain nerves, increasing the sensation of pain.
Researchers at Scripps Research Institute describe two new drug scaffolds that target the kappa opioid receptor, offering novel tools for treating pain, addiction, and other disorders. The compounds, called biased agonists, activate the receptor without recruiting beta arrestin, a molecule associated with depression.
Researchers discovered how sodium controls opioid receptors, a major class of brain cell receptors. The findings suggest new therapeutic approaches to treat pain and mood disorders. Sodium's effect on receptor activity is crucial for developing better opioid-receptor-targeting drugs.
Researchers at the University of Missouri have developed a comprehensive, nonsurgical treatment that significantly improves symptoms of pelvic floor dysfunction in women. The treatment involves muscle strengthening and relaxation techniques, resulting in an average 80% improvement in urinary incontinence, defecatory dysfunction, and pe...
A study by Beth Israel Deaconess Medical Center found that patients' expectations, whether positive, negative, or neutral, significantly influence the effects of both medications and placebos on migraine pain. The researchers discovered that a positive message and powerful medication are essential for effective clinical care.
Researchers at University of Nottingham discovered a potential drug to reduce osteoarthritis pain by targeting cannabinoid receptor2 (CB2), which also reduces joint inflammation. The synthetic compound JWH133 showed promise in animal models and human spinal cord tissue studies.
Research finds mTOR activation in neurons of dorsal horn contributes to morphine tolerance and hyperalgesia; rapamycin treatment improves opioid tolerance and hyperalgesia in rats. Targeting the mTOR pathway may enhance pain management.
Researchers from the University of California, Irvine, have identified a new natural compound in a traditional Chinese medicine plant that relieves chronic pain. The compound, dehydrocorybulbine (DHCB), acts on dopamine receptors and shows promise for treating low-level chronic pain without losing effectiveness over time.
Researchers discovered a compound in traditional Chinese herbal medicine that effectively alleviates both inflammatory and nerve pain, with no tolerance to addiction. The compound, dehydrocorybulbine, was found to be reproducible and has potential as a new nonaddictive treatment for chronic neuropathic pain.
A recent study led by Boston University School of Medicine researchers found that diflunisal successfully reduced neurological decline and preserved quality of life in patients with familial transthyretin amyloidosis. This repurposed generic drug demonstrates an effective alternative to liver transplantation for this devastating disease.
Researchers at Umeå University detected measurable concentrations of illicit drugs in Swedish wastewater from 33 treatment plants. The study found 13 different narcotic substances, with oxazepam, codeine, and morphine being the most common prescription drug residues.
A large study found that patients receiving etomidate for anesthesia may be at increased risk of mortality and cardiovascular events, with a 250% increase in death risk compared to those receiving propofol. The results have sparked concerns over the safety of etomidate use.
A study by Dana-Farber Cancer Institute and Yale University found that moderate daily exercise can decrease joint pain in postmenopausal women taking aromatase inhibitors for breast cancer. After a year, joint pain scores decreased by 20% in the exercise group compared to 3% in the non-exercise group.
The American College of Physicians recommends clinical and administrative changes to deter prescription drug abuse while maintaining patient access to treatment. The guidelines advocate for physician, patient, and public education on the harms of medical and nonmedical use of prescription drugs.
The study examined changes in brain functional activity and central networks in subjects with migraine undergoing acupuncture at Shaoyang uncommon acupoints. Acupuncture has been shown to be a recommended treatment for migraine sufferers, but the central analgesic mechanism remains poorly understood.
A new study suggests that vaginal administration of erectile dysfunction medication sildenafil citrate may alleviate moderate to severe menstrual cramps with no reported side effects. Researchers found that the drug relieved pain by increasing blood flow, but the exact mechanism remains unknown.
Researchers have determined the structure of TRPV1, a protein that plays a central role in pain perception and heat sensation, at near-atomic resolution using electron cryo-microscopy. This breakthrough offers fresh insights to drug designers searching for new pain treatments and sheds light on the protein's unique properties.
Researchers found that oxycodone is the most popular drug due to its high quality, while hydrocodone remains a favorite despite lower euphoric qualities. Hydrocodone's popularity stems from its affordability, ease of access, and perceived safety, making it an attractive option for risk-averse users.
A global survey by the European Society for Medical Oncology found that over half of the world's population lives in countries with regulations limiting access to opioid medicines for managing cancer pain. The study highlights the need for regulatory reform and education to improve access to these medicines.
A study found that people taking statin drugs often take an average of three other medications that can cause muscle pain and lead to discontinued use, a major contributor to the side effect. Researchers recommend adjusting dosages or choosing alternative medications to minimize interactions.
Researchers discovered that Δ9-THC causes an increase in COX-2 levels, leading to memory impairments. Taking an over-the-counter painkiller like ibuprofen can prevent these side effects by inhibiting COX-2 levels.
Taking aspirin at bedtime instead of in the morning could reduce acute heart events by reducing platelet activity. A randomized study found that taking aspirin at bedtime resulted in a 22-unit reduction in platelet activity compared to taking it in the morning.
Researchers used brain imaging to track pregabalin's effects on fibromyalgia patients, finding reduced glutamate levels and decreased insula connectivity. This study suggests a future of targeted brain imaging approaches for chronic widespread pain treatment.
A study analyzing over 1 million hospital admissions found that over 50% of nonsurgical patients were prescribed opioids, with high doses and late discharge increasing the risk of adverse events. Regional variation in prescribing rates was also observed, with a 37% difference between the highest and lowest regions.
A new study reveals a sharp rise in US drug poisoning deaths by county, with both urban and rural areas experiencing significant increases. Rural areas showed a greater percentage increase in death rates, highlighting the need for targeted policies and programs to address this growing public health concern.
A study by CU-Boulder researchers found that using morphine to treat post-operative pain after abdominal surgery can actually prolong recovery time and increase suffering. The scientists discovered that both morphine and the surgery itself activate glial cells, leading to additional pain signals.
Patients should never drive if taking narcotic pain medication, as it impairs cognitive judgment and reaction time. Additionally, using one arm can significantly limit safe driving abilities due to impaired coordination and control of the vehicle.
A clinical trial found gabapentin to be safe and effective in treating alcohol dependence, reducing cravings, depression, and sleeplessness. The drug's effect on drinking outcomes was at least as large as existing FDA-approved treatments, with significant benefits seen in patients who received the high-dose regimen.
A University of Southampton study has found that ibuprofen provides no benefit for patients with respiratory tract infections, including colds and sore throats. The research also showed that steam inhalation has no clear symptom-relieving effect, while ibuprofen may actually contribute to the progression of illness in some individuals.
A study published in Journal of General Internal Medicine found that long-term opioid use is linked to a higher risk of developing major depression. Patients who used opioids for 180 days or longer were at a 53% increased risk, while those using them for 90-180 days had a 25% increased risk.
Researchers develop a new molecule combining elements of Botox and tetanus toxin to alleviate inflammatory pain, offering potential relief for chronic pain conditions and epilepsy. The engineered molecule could improve quality of life for those suffering from chronic pain with a single injection providing prolonged pain relief.
A new study suggests that prenatal exposure to paracetamol may increase the risk of adverse effects on child development, including poorer gross motor skills and behavioral problems. The study found that occasional use for short periods is likely not harmful to the fetus, but more research is needed to confirm these results.
A new University of Michigan study finds that 10.4% of teens and young adults treated in the emergency room admitted to misusing prescription painkillers or sedatives at least once in the last year. The study suggests that emergency departments could be an effective setting for screening and intervening early before problems arise.
A study of liposomal bupivacaine found it produces femoral nerve block lasting longer than 24 hours in volunteers, but the results are not straightforward due to variable responses and an inverse relationship between dose and response. Larger trials will be needed before the product can be recommended for routine clinical use.
Remimazolam, a benzodiazepine-type sedative drug, has shown promising results as an alternative to conventional sedatives in colonoscopy procedures. The medication provides adequate sedation with a fast onset and quick recovery time, making it a valuable option for patients undergoing brief medical procedures.
A new drug, Linaclotide, has been found to effectively relieve abdominal pain in IBS-C patients through a novel physiological pathway. The study's findings provide significant relief for approximately one-third of IBS-C sufferers who have struggled with this debilitating condition.
A study found that intranasal application of hormone oxytocin enhanced placebo analgesia response. The researchers observed greater pain reduction on the placebo site after applying oxytocin compared to saline.
Research found analgesic overdose deaths concentrated in economically disadvantaged neighborhoods with high divorce rates and single-parent homes. However, these deaths occurred less often in higher-income neighborhoods than heroin overdose deaths.
Researchers at WashU Medicine found that chronic itching incorporates more neurons than normal itch signals and co-opts pain neurons to intensify the sensation. This discovery may lead to more effective treatments targeting activity in both pain and itch neurons.
Researchers at CNIO discovered that Fra-1 protein protects the liver from drug-induced damage and neutralizes toxins. This new regulatory mechanism could lead to future studies on new drugs for diseases related to toxic compound accumulation.
Researchers have found that applying ice packs after major abdominal operations reduces postoperative pain and opioid use, with patients experiencing 50% less pain on the first and third days. An experimental prolonged drug delivery system using lidocaine also showed superior results in animal studies.
A study in the Journal of Addiction Medicine finds that doctors abuse prescription drugs primarily for 'self-medication' to manage physical or emotional pain, stress, and psychiatric symptoms. The study highlights the importance of addressing self-medication as a key reason for prescription drug abuse among physicians.
A new Kaiser Permanente study found that 77% of obese patients who used opioids before bariatric surgery continued to use them chronically after surgery. Chronic opioid use increased by 13% in the first year after surgery.
Researchers at Henry Ford Hospital found that over-the-counter ibuprofen is just as effective as prescription pain medications in reducing post-operative pain after a tonsillectomy. The study, which enrolled 91 patients aged 3-38, showed no significant difference in pain control between the three groups.
Researchers discovered that aspirin improves survival in patients with colon cancer whose tumour cells express Human Leukocyte Antigen class I (HLA class I), a cell-surface protein involved in the immune system. The study found that HLA class I could be used to predict which patients benefit from aspirin therapy.
Benzathine penicillin G's supply is intermittent in many countries due to quality control issues and low administration rates. Novel delivery devices are proposed to improve accessibility to this life-changing intervention.
A recent Rhode Island Hospital study found that improving law enforcement's role in responding to overdose emergencies could significantly impact the number of overdose deaths. The study revealed that officers are often frustrated by limitations to their medical role and lack clarity on what they can do at the scene.
Researchers isolated and identified a naturally occurring analgesic compound from the root bark of Nauclea latifolia, identical to commercially available Tramadol. The discovery confirms high concentrations of Tramadol in the plant, providing new prospects for local populations and validating traditional medicine.
A recent study published in The Lancet Oncology shows that abiraterone acetate significantly delays pain progression and quality of life deterioration when taken with prednisone. Patients experienced a more than eight-month delay in pain progression and a four-month delay in quality of life decline.
A study of over 2,200 children's hospital visits reveals racial and ethnic disparities in pain management and length of stay for abdominal pain. Black and Hispanic children were less likely to receive analgesics, while black patients had shorter hospital stays compared to white children.
A study published in Medical Care reports a sharp increase in opioid prescribing for non-cancer pain, while safer alternatives like ibuprofen and acetaminophen have either stayed flat or declined. The study highlights the need for re-evaluation of pain treatment approaches that prioritize non-opioid and non-pharmacologic treatments.
A new study finds no improvement in pain treatment with rising opioid prescriptions, despite efforts to increase awareness and alternative treatments. Non-opioid analgesics have plateaued or declined in many cases.
Researchers from the University of Adelaide found that codeine provides less pain relief than morphine but increases sensitivity to pain equally. This could be a problem for individuals with chronic pain who need ongoing medication, highlighting the need for further research and potential alternatives.
Scientists have developed a new form of aspirin that could extend its benefits to people who don't respond to the drug, addressing 'aspirin resistance'. The new aspirin form is linked to a carrier protein that delivers aspirin directly to damaged blood vessels, releasing it and stopping clot-formation.
The PRAGUE 14 trial found no correlation between pre-surgical interruption of antithrombotic therapy and perioperative cardiovascular or bleeding complications. Instead, factors like high platelet count, prosthetic valve presence, age, and acute surgery were identified as independent risk factors.
Aromatherapy has been shown to be a promising, non-invasive treatment for postoperative nausea, with patients receiving essential oil blends experiencing lower nausea scores. Additionally, intravenous administration of a five percent solution of dextrose may reduce the need for antiemetic medications and shorten recovery time.
Chronic pain affects an estimated 100 million US residents, costing $635 billion annually in healthcare costs and lost productivity. To address this issue, physicians must consider the psychological, social, and cultural contexts of their patients, as well as medication risks and benefits.
A Duke University study found that a compound called neuroprotectin D1 can relieve neuropathic pain caused by nerve injuries. The derivative of DHA, a main ingredient of fish oil supplements, inhibits the production of cytokines and chemokines, protecting nerve cells from further damage.
Long-term aspirin use has been linked to reduced colorectal cancer risk, but alternate-day dosing shows increased gastrointestinal bleeding. Electronic health records adoption led to ambulatory cost savings of 3% per member per month and reductions in radiology costs in experimental pilot communities.
Researchers have identified a new chemical compound, CYM51010, that targets the opioid receptor complex and shows promise as an alternative to morphine. The compound is potent and less likely to result in tolerance and negative side effects.